Jazz Pharmaceuticals plc: director Bruce C Cozadd sold 6,000 shares

What happened Bruce C Cozadd, director, sold 6,000 shares of Jazz Pharmaceuticals plc at $230.33 per share on Oct 1, 2026, for $1,381,980, according to the Form 4 filed on Oct 5, 2026. The Form 4 lists the transaction as a sale (S), open market or private sale.

Key details

• transaction date and price: Oct 1, 2026; $230.33 per share; 6,000 shares; total $1,381,980.
• filing date: Oct 5, 2026.
• shares owned after the transaction: not reported in the Form 4.
• footnote: the sale was made pursuant to a Rule 10b5-1 plan adopted on Nov 26, 2025; the transaction occurred automatically and was not a discretionary trade by the reporting person (footnote F1).
• transaction code: S (sale).

Why it may matter The Form 4 states the sale was executed under a Rule 10b5-1 trading plan adopted Nov 26, 2025 and occurred automatically under that plan. A filing does not show why the insider traded or why the company acted.